Intercept Pharmaceuticals (ICPT) PT Raised to $69 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald raised its price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $69.00 (from $58.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
